Tesamorelin 10mg

Tesamorelin is a 44-amino-acid GHRH analog stabilised by a trans-3-hexenoic acid modification that resists dipeptidyl peptidase-IV cleavage, supporting sustained receptor engagement and prolonged IGF-1 elevation. It is among the most extensively characterised GHRH analogs in the visceral adiposity and metabolic-modulation literature. The 10mg presentation positions it for extended-duration studies and laboratories requiring larger working stocks for longitudinal metabolic protocols.

Supplied as a lyophilised peptide vial, supplied for reconstitution with bacteriostatic water. The 10mg size suits extended visceral adiposity protocols, multi-week IGF-1 monitoring and institutional laboratories where the larger format delivers improved unit cost and supply consistency.

Research Applications • Extended visceral adipose tissue and central adiposity reduction studies • Longitudinal IGF-1 elevation and somatotropic feedback characterisation • Multi-week GHRH receptor engagement and tachyphylaxis research • Sustained lipid metabolism and triglyceride modulation investigation

Specification • Identity: Tesamorelin (CAS 218949-48-5) • Molecular weight: 5135.83 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised peptide vial — reconstitute with bacteriostatic water before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.